Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review, 60878-60879 [2013-24063]

Download as PDF 60878 Federal Register / Vol. 78, No. 191 / Wednesday, October 2, 2013 / Notices For Further Information Contact: Felicia Betancourt, National Center for Immunization and Respiratory Diseases, CDC, 1600 Clifton Road NE., MS–A27, Atlanta, Georgia 30333, telephone 404/639– 8836; Email ACIP@CDC.GOV The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2013–24061 Filed 10–1–13; 8:45 am] Officer, CDC, 4770 Buford Highway NE., Mailstop F–80, Atlanta, Georgia 30341, Telephone: (770) 488–3585, Email: EEO6@cdc.gov. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. Telephone: (770) 488–3585, Email: EEO6@cdc.gov. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2013–24062 Filed 10–1–13; 8:45 am] BILLING CODE 4163–18–P [FR Doc. 2013–24067 Filed 10–1–13; 8:45 am] BILLING CODE 4160–18–P BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES DEPARTMENT OF HEALTH AND HUMAN SERVICES DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Centers for Disease Control and Prevention Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review tkelley on DSK3SPTVN1PROD with NOTICES The meeting announced below concerns Health Promotion and Disease Prevention Research Centers, Funding Opportunity Announcement (FOA) DP14–001, initial review. In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the aforementioned meeting: Times and Dates 8 a.m.–6:30 p.m., November 18, 2013 (Closed) 8 a.m.–6:30 p.m., November 19, 2013 (Closed) 8 a.m.–6:30 p.m., November 20, 2013 (Closed) 8 a.m.–6:30 p.m., November 21, 2013 (Closed) Place: Centers for Disease Control and Prevention, 1600 Clifton Road NE., Global Communications Center, Auditorium B, Atlanta, Georgia 30333. Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c) (4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92– 463. Matters To Be Discussed: The meeting will include the initial review, discussion, and evaluation of ‘‘Health Promotion and Disease Prevention Research Centers, FOA DP14–001’’. For Further Information Contact: M. Chris Langub, Ph.D., Scientific Review VerDate Mar<15>2010 17:48 Oct 01, 2013 Jkt 232001 Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review The meeting announced below concerns Health Promotion and Disease Prevention Research Centers, Funding Opportunity Announcement (FOA) DP14–001, initial review. In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the aforementioned meeting: Times And Dates 8 a.m.–6:30 p.m., November 18, 2013 (Closed); 8 a.m.–6:30 p.m., November 19, 2013 (Closed); 8 a.m.–6:30 p.m., November 20, 2013 (Closed); 8 a.m.– 6:30 p.m., November 21, 2013 (Closed). Place: Centers for Disease Control and Prevention, 1600 Clifton Road NE., Global Communications Center, Auditorium B, Atlanta, Georgia 30333. Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92– 463. Matters To Be Discussed: The meeting will include the initial review, discussion, and evaluation of ‘‘Health Promotion and Disease Prevention Research Centers, FOA DP14–001’’. For Further Information Contact: M. Chris Langub, Ph.D., Scientific Review Officer, CDC, 4770 Buford Highway NE., Mailstop F–80, Atlanta, Georgia 30341, PO 00000 Frm 00063 Fmt 4703 Sfmt 4703 Centers for Disease Control and Prevention Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review The meeting announced below concerns National Center for Construction Safety and Health Research and Translation (U60, Request for Application (RFA) OH13–001, initial review. In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the aforementioned meeting: Time and Date: 8 a.m.–5 p.m., November 19, 2013 (Closed); 8 a.m.–5 p.m., November 20, 2013 (Closed); 8 a.m.–12 p.m., November 21, 2013 (Closed). Place: Embassy Suites Alexandria Hotel, 1900 Diagonal Road, Alexandria, Virginia 22314, Telephone: (703)842– 7030. Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92– 463. Matters To Be Discussed: The meeting will include the initial review, discussion, and evaluation of applications received in response to ‘‘National Center for Construction Safety and Health Research and Translation (U60), RFA OH13–001.’’ For Further Information Contact: George Bockosh, M.S., Scientific Review Officer, CDC/NIOSH, 626 Cochrans Mill Road, Mailstop P–05, Pittsburgh, Pennsylvania 15236, Telephone: (412) E:\FR\FM\02OCN1.SGM 02OCN1 Federal Register / Vol. 78, No. 191 / Wednesday, October 2, 2013 / Notices 386–6465 and Joan Karr, Ph.D., Scientific Review Officer, CDC/NIOSH, 1600 Clifton Road, Mailstop E–74, Atlanta, Georgia 30333, Telephone: (404) 498–2506. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Elaine L. Baker, Director, Management Analysis and Services Office Centers for Disease Control and Prevention. [FR Doc. 2013–24063 Filed 10–1–13; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review The meeting announced below concerns National Center for Construction Safety and Health Research and Translation (U60, Request for Application (RFA) OH13–001, initial review. In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the aforementioned meeting: Time and Date: 8 a.m.–5 p.m., November 19, 2013 (Closed); 8 a.m.–5 p.m., November 20, 2013 (Closed); 8 a.m.–12 p.m., November 21, 2013 (Closed). Place: Embassy Suites Alexandria Hotel, 1900 Diagonal Road, Alexandria, Virginia 22314, Telephone: (703) 842– 7030. Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92– 463. Matters To Be Discussed: The meeting will include the initial review, discussion, and evaluation of applications received in response to ‘‘National Center for Construction Safety and Health Research and Translation (U60), RFA OH13–001.’’ For Further Information Contact: George Bockosh, M.S., Scientific Review Officer, CDC/NIOSH, 626 Cochrans Mill Road, Mailstop P–05, Pittsburgh, Pennsylvania 15236, Telephone: (412) 386–6465 and Joan Karr, Ph.D., Scientific Review Officer, CDC/NIOSH, 1600 Clifton Road, Mailstop E–74, Atlanta, Georgia 30333, Telephone: (404) 498–2506. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. 60879 Description: The Program Instruction, prepared in response to the enactment of the Childrens Justice Act (CJA), Title II of Public Law 111–320, Child Abuse Prevention and Treatment Act Reauthorization of 2010, provides direction to the States and Territories to accomplish the purposes of assisting States in developing, establishing and operating programs designed to improve: (1) The assessment and investigation of suspected child abuse and neglect cases, including cases of suspected child sexual abuse and exploitation, in a manner that limits additional trauma to the child and the child’s family; (2) the assessment and investigation of cases of suspected child abuse-related fatalities and suspected child neglect-related fatalities; (3) the investigation and prosecution of cases of child abuse and neglect, including child sexual abuse and exploitation; and (4) the assessment and investigation of cases involving children with disabilities or serious health-related problems who are suspected victims of child abuse or neglect. This Program Instruction contains information collection requirements that are found in Public Law 111–320 at Sections 107(b) and 107(d), and pursuant to receiving a grant award. The information being collected is required by statute to be submitted pursuant to receiving a grant award. The information submitted will be used by the agency to ensure compliance with the statute; to monitor, evaluate and measure grantee achievements in addressing the investigation and prosecution of child abuse and neglect; and to report to Congress. Respondents: State Governments. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2013–24066 Filed 10–1–13; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Administration for Children and Families Proposed Information Collection Activity; Comment Request Proposed Projects Title: ACF Program Instruction: Children’s Justice Act. OMB No.: 0970–0425. ANNUAL BURDEN ESTIMATES Number of respondents Number of responses per respondent Average burden hours per response Total burden hours Application & Annual Report ........................................................... tkelley on DSK3SPTVN1PROD with NOTICES Instrument 52 1 60 3,120 Estimated Total Annual Burden Hours: 3,120. In compliance with the requirements of Section 506(c)(2)(A) of the Paperwork Reduction Act of 1995, the Administration for Children and VerDate Mar<15>2010 17:48 Oct 01, 2013 Jkt 232001 Families is soliciting public comment on the specific aspects of the information collection described above. Copies of the proposed collection of information can be obtained and comments may be forwarded by writing PO 00000 Frm 00064 Fmt 4703 Sfmt 4703 to the Administration for Children and Families, Office of Planning, Research and Evaluation, 370 L’Enfant Promenade SW., Washington, DC 20447, Attn: ACF Reports Clearance Officer. Email address: infocollection@ E:\FR\FM\02OCN1.SGM 02OCN1

Agencies

[Federal Register Volume 78, Number 191 (Wednesday, October 2, 2013)]
[Notices]
[Pages 60878-60879]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-24063]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel (SEP): Initial Review

    The meeting announced below concerns National Center for 
Construction Safety and Health Research and Translation (U60, Request 
for Application (RFA) OH13-001, initial review.
    In accordance with Section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the aforementioned meeting:
    Time and Date: 8 a.m.-5 p.m., November 19, 2013 (Closed); 8 a.m.-5 
p.m., November 20, 2013 (Closed); 8 a.m.-12 p.m., November 21, 2013 
(Closed).
    Place: Embassy Suites Alexandria Hotel, 1900 Diagonal Road, 
Alexandria, Virginia 22314, Telephone: (703)842-7030.
    Status: The meeting will be closed to the public in accordance with 
provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and 
the Determination of the Director, Management Analysis and Services 
Office, CDC, pursuant to Public Law 92-463.
    Matters To Be Discussed: The meeting will include the initial 
review, discussion, and evaluation of applications received in response 
to ``National Center for Construction Safety and Health Research and 
Translation (U60), RFA OH13-001.''
    For Further Information Contact: George Bockosh, M.S., Scientific 
Review Officer, CDC/NIOSH, 626 Cochrans Mill Road, Mailstop P-05, 
Pittsburgh, Pennsylvania 15236, Telephone: (412)

[[Page 60879]]

 386-6465 and Joan Karr, Ph.D., Scientific Review Officer, CDC/NIOSH, 
1600 Clifton Road, Mailstop E-74, Atlanta, Georgia 30333, Telephone: 
(404) 498-2506.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities, 
for both the Centers for Disease Control and Prevention and the Agency 
for Toxic Substances and Disease Registry.

Elaine L. Baker,
Director, Management Analysis and Services Office Centers for Disease 
Control and Prevention.
[FR Doc. 2013-24063 Filed 10-1-13; 8:45 am]
BILLING CODE 4163-18-P